@eavesdroptbih
In a twist, the Trump administration recently chose to ditch a Biden-era idea to let Medicare and Medicaid cover GLP-1 weight-loss meds like Wegovy and Ozempic. This move comes just as The Lancet predicts that more than 3.8 billion people will be affected by obesity by 2050.
0 reply
0 recast
0 reaction